GTHCX Mutual Fund

NAV$17.81

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
1.82%
Dividend Yield (Current)
12.26%
Holdings
81
Inception Date
Mar 1, 1999
Fund Family
Invesco (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+3.16%
1 Year+15.29%
3 Year+10.13%
5 Year+10.73%
10 Year+14.07%

Asset Allocation

Stocks: 95.79%
Cash: 4.21%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company9.07%
JNJJOHNSON AND JOHNSON5.81%
AZN:LNAstrazeneca Plc Adr4.34%
GILDGilead Sciences Inc4.10%
ABBVAbbvie Inc Health Care3.67%
Top 10 Concentration: 42.62%Report Date: Mar 31, 2026
Download all 81 holdings for GTHCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
12.26%
Frequency
Annually
Latest Distribution
$9.93
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how GTHCX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

GTHCX Mutual Fund Overview

GTHCX Mutual Fund (Invesco Health Care Fund Class C) is managed by Invesco (US). GTHCX expense ratio is 1.82%, holding 81 positions across sectors including Health Care, Unknown, Real Estate. Inception date: 1999-03-01.

GTHCX performance shows a YTD return of 3.16%. The 1-year return is 15.29% and the 5-year return is 10.73%. GTHCX dividend yield stands at 12.26%, paid annually.

GTHCX top holdings include Eli Lilly And Company (9.1%), JOHNSON AND JOHNSON (5.8%), Astrazeneca Plc Adr (4.3%), Gilead Sciences Inc (4.1%), Abbvie Inc Health Care (3.7%). View all GTHCX holdings, sector breakdown, or dividend history.

GTHCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. GTHCX alternatives are available via the screener, along with tax-loss harvesting opportunities.